of eight years, Ma found Chinese patients with advanced nasopharyngeal cancer suffered more side

effects than benefits from the additional chemotherapy, which cost about 13,400 yuan ($2,000) per patient.

The findings, published in the journal Lancet Oncology in 2012, drew the attention of

Western experts, and the United States and Europe revised their treatment guidelines.

More recently, Ma added a new drug to the original dual drug ch

emotherapy regimen, and moved post-radiotherapy chemotherapy to pre-radiotherapy.

In another clinical study of 480 cases, Ma and his team found th

at this regimen increased the five-year survival rate of patients by 8 percent.

The nasopharynx is in the upper part of the pharynx behind the nose, connecting the nostr

ils and throat. The location makes it hard for doctors to operate, so radiotherapy is the first choice

shlfdd.com